Tag: Marketwatch

Jan 03
Pfizer, BioNTech booster shot EUA expanded to include children 12 years old

Pfizer Inc. PFE, -3.24% and BioNTech SE BNTX, -5.52% announced Monday that the U.S. Food and Drug Administration has granted Emergency Use Authorization of a booster dose of the companies’ COVID-19 vaccine into people ages 12 years and older. Previously, the FDA had only authorized a booster for people aged 16 years and older. “The […]

Jan 03
Nio's stock surges after reporting deliveries more than doubled in 2021

Shares of Nio Inc. NIO, -2.28% shot up 4.6% in premarket trading Monday, after the China-based electric vehicle maker announced record fourth-quarter deliveries. The stock’s bounce comes after it tumbled 19.0% in December, the worst monthly performance since it dropped 19.7% in February, and hit a 14-month closing low of $28.16 on Dec. 20. Over […]

Jan 03
Coronavirus tally: Hospitalizations spike above 90,000 as COVID-19 cases leap to a record above 400,000

There’s still no sign of a reprieve at the start of the new year, as daily average of COVID-19 cases and hospitalizations continued to rocket higher, although, while deaths hold relatively steady. The seven-day average of COVID-19-related hospitalizations climbed to 93,322 on Sunday, up 35% from two weeks ago and the most since Sept. 16, […]

Jan 02
Biogen shares slump after Samsung Biologics denial of buyout report

Steven Goldstein is based in London and responsible for MarketWatch’s coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was Washington bureau chief, directing MarketWatch’s economic, political and regulatory coverage. Follow Steve on Twitter: @MKTWgoldstein. Source: Marketwatch

Jan 01
J&J's COVID-19 vaccine booster was 85% effective against hospitalization, in South Africa study

Johnson & Johnson JNJ, -0.72% said Thursday that a South African Phase 3 study showed that its a booster shot of its COVID-19 vaccine was 85% effective in preventing COVID-19-related hospitalization. The drug maker said the study, conducted by the South African Medical Research Council, was conducted from mid-November to mid-December, which is after omicron […]

Jan 01
Kroger stock rises after new $1 billion stock buyback program authorized

Shares of Kroger Co. KR, +0.27% rose 0.9% in premarket trading Thursday, putting them on track for a fourth-straight gain, after the supermarket operator announced a new $1 billions stock repurchase program. The company said the new program replaces the current program, which had about $157 million remaining. The new program represents roughly 3% of […]

Jan 01
Royal Caribbean plays down impact of omicron on cruises, longer-term results and stock rallies

Shares of Royal Caribbean Group RCL, -0.58% jumped 1.7% in morning trading Thursday, after the cruise operator looked to play down the impact of the omicron variant of the coronavirus on cruises, saying the impact on bookings has been less than what was experienced with the delta variant. The company said near-term results will be […]

Jan 01
Coronavirus tally: Parabolic surge in average daily cases continues, and hospitalizations top 80,000

The seven-day average of COVID-19 cases in the U.S. continued its parabolic climb to 344,543 on Thursday, up from 301,477 on Wednesday, up about four-fold since Dec. 1 and 37% above the January 2021 daily peak of 251,232, according to a New York Times tracker. Hospitalizations also kept climbing, but at a slower pace, as […]

Jan 01
U.K. approves Pfizer oral antiviral Paxlovid for COVID-19

The U.K. Medicines and Healthcare products Regulatory Agency said it’s approved Pfizer’s PFE, +1.11% Paxlovid oral antiviral for people with mild to moderate COVID-19 and have at least one risk factor for developing severe illness. The regulator last month had approved Merck’s MRK, -0.65% Lagevrio. The regulator said it is too early to know whether […]

Jan 01
Zepp Health's stock drops after revenue outlook cut, citing COVID effect and chip shortage

Shares of Zepp Health Corp. ZEPP, dropped 4.0% in premarket trading Friday, after the China-based smart health technology company cut its fourth-quarter revenue outlook, citing a “greater than anticipated effects of COVID” and a more persistent global shortage of semiconductors. The company now expects fourth-quarter revenue of between RMB1.6 billion ($252.0 million) and RMB1.75 billion […]